Global Market of Monoclonal Antibodies: Sales, Prices, Demand
Bio-pharmaceutics is one of the most science-intensive industries. Annually a lot of money is spent on applied research aimed at development and commercialization of new medications. Many pharmaceutical companies try to have in their product line or pipeline drugs on the basis of monoclonal antibodi...
Enregistré dans:
Auteur principal: | |
---|---|
Format: | article |
Langue: | RU |
Publié: |
Plekhanov Russian University of Economics
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1a41fb7c978246e0837d4972590966d0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
id |
oai:doaj.org-article:1a41fb7c978246e0837d4972590966d0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1a41fb7c978246e0837d4972590966d02021-11-15T05:20:50ZGlobal Market of Monoclonal Antibodies: Sales, Prices, Demand2413-28292587-925110.21686/2413-2829-2021-2-64-76https://doaj.org/article/1a41fb7c978246e0837d4972590966d02021-04-01T00:00:00Zhttps://vest.rea.ru/jour/article/view/1049https://doaj.org/toc/2413-2829https://doaj.org/toc/2587-9251Bio-pharmaceutics is one of the most science-intensive industries. Annually a lot of money is spent on applied research aimed at development and commercialization of new medications. Many pharmaceutical companies try to have in their product line or pipeline drugs on the basis of monoclonal antibodies, i.e. a class of biotechnological preparations that are used to combat oncologic and autoimmune diseases and are based on target therapy principle. Because of the high interest in bio-pharmaceutical industry on the part of businessmen, state and science any advanced data dealing with the situation inside the market can be useful for shaping the adequate picture of the present day condition and for making managerial decisions on state and private level. The article provides information about global sales of preparations based on monoclonal antibodies. Apart from sales in terms of money the author calculates the natural volume of products being sold based on price analysis of products. The article gives a list of preparations registered on EU and US markets rated by their sales. By analyzing preparation prices corrected to dosage it was possible to find the most expensive and the cheapest medications in their class. Information concerning the natural volume of drug being sold can help understand the scale of preparation production.D. A. UvarovPlekhanov Russian University of Economicsarticlebio-pharmaceuticspharmaceutical marketmonoclonal antibodiesbio-analoguesbio-similarssalesbiotechnologiestarget therapybigpharmaindustriesinnovation productionEconomics as a scienceHB71-74RUВестник Российского экономического университета имени Г. В. Плеханова, Vol 18, Iss 2, Pp 64-76 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
bio-pharmaceutics pharmaceutical market monoclonal antibodies bio-analogues bio-similars sales biotechnologies target therapy bigpharma industries innovation production Economics as a science HB71-74 |
spellingShingle |
bio-pharmaceutics pharmaceutical market monoclonal antibodies bio-analogues bio-similars sales biotechnologies target therapy bigpharma industries innovation production Economics as a science HB71-74 D. A. Uvarov Global Market of Monoclonal Antibodies: Sales, Prices, Demand |
description |
Bio-pharmaceutics is one of the most science-intensive industries. Annually a lot of money is spent on applied research aimed at development and commercialization of new medications. Many pharmaceutical companies try to have in their product line or pipeline drugs on the basis of monoclonal antibodies, i.e. a class of biotechnological preparations that are used to combat oncologic and autoimmune diseases and are based on target therapy principle. Because of the high interest in bio-pharmaceutical industry on the part of businessmen, state and science any advanced data dealing with the situation inside the market can be useful for shaping the adequate picture of the present day condition and for making managerial decisions on state and private level. The article provides information about global sales of preparations based on monoclonal antibodies. Apart from sales in terms of money the author calculates the natural volume of products being sold based on price analysis of products. The article gives a list of preparations registered on EU and US markets rated by their sales. By analyzing preparation prices corrected to dosage it was possible to find the most expensive and the cheapest medications in their class. Information concerning the natural volume of drug being sold can help understand the scale of preparation production. |
format |
article |
author |
D. A. Uvarov |
author_facet |
D. A. Uvarov |
author_sort |
D. A. Uvarov |
title |
Global Market of Monoclonal Antibodies: Sales, Prices, Demand |
title_short |
Global Market of Monoclonal Antibodies: Sales, Prices, Demand |
title_full |
Global Market of Monoclonal Antibodies: Sales, Prices, Demand |
title_fullStr |
Global Market of Monoclonal Antibodies: Sales, Prices, Demand |
title_full_unstemmed |
Global Market of Monoclonal Antibodies: Sales, Prices, Demand |
title_sort |
global market of monoclonal antibodies: sales, prices, demand |
publisher |
Plekhanov Russian University of Economics |
publishDate |
2021 |
url |
https://doaj.org/article/1a41fb7c978246e0837d4972590966d0 |
work_keys_str_mv |
AT dauvarov globalmarketofmonoclonalantibodiessalespricesdemand |
_version_ |
1718428601706086400 |